88 related articles for article (PubMed ID: 6605971)
1. Analysis of the antimalarial, mefloquine, in blood and plasma using high-performance liquid chromatography.
Kapetanovic IM; DiGiovanni JD; Bartosevich J; Melendez V; Von Bredow J; Heiffer M
J Chromatogr; 1983 Oct; 277():209-15. PubMed ID: 6605971
[TBL] [Abstract][Full Text] [Related]
2. Determination of mefloquine in biological fluids using high performance liquid chromatography.
Karbwang J; Molunto P; Na Bangchang K; Bunnag D
Southeast Asian J Trop Med Public Health; 1989 Mar; 20(1):55-60. PubMed ID: 2788925
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of the antimalarial agent, mefloquine, in blood, plasma, and urine using high-pressure liquid chromatography.
Grindel JM; Tilton PF; Shaffer RD
J Pharm Sci; 1977 Jun; 66(6):834-7. PubMed ID: 874785
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of mefloquine and chloroquine in biological fluids using high-performance liquid chromatography.
Lamant JM; Kintz P; Tracqui A; Mangin P; Lugnier AA; Chaumont AJ
Ann Biol Clin (Paris); 1988; 46(9):722-4. PubMed ID: 3265602
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic assay for the simultaneous monitoring of mefloquine and its acid metabolite in biological samples using protein precipitation and ion-pair extraction.
Bergqvist Y; Hellgren U; Churchill FC
J Chromatogr; 1988 Nov; 432():253-63. PubMed ID: 3265419
[TBL] [Abstract][Full Text] [Related]
6. An Alternative HPLC with Ultraviolet Detection for Determination of Piperaquine in Plasma.
Choemang A; Na-Bangchang K
J Chromatogr Sci; 2019 Jan; 57(1):27-32. PubMed ID: 30169629
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic analysis of mefloquine and its main metabolite by direct plasma injection with pre-column enrichment and column switching techniques.
Arnold PJ; Stetten OV
J Chromatogr; 1986 Feb; 353():193-200. PubMed ID: 3486187
[TBL] [Abstract][Full Text] [Related]
8. Reversed-phase liquid chromatographic method for the simultaneous determination of the antimalarial drugs sulfadoxine, pyrimethamine, mefloquine and its major carboxylic metabolite in plasma.
Bergqvist Y; Eckerbom S; Larsson H; Malekzadeh M
J Chromatogr; 1991 Nov; 571(1-2):169-77. PubMed ID: 1810945
[TBL] [Abstract][Full Text] [Related]
9. Studies of the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR 30,090.
Mu JY; Israili ZH; Dayton PG
Drug Metab Dispos; 1975; 3(3):198-210. PubMed ID: 238819
[TBL] [Abstract][Full Text] [Related]
10. Determination of NVP-BEZ235, a dual PI3K and mTOR inhibitor, in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography with fluorescence detection.
Lin F; Chandrasekaran G; de Gooijer MC; Beijnen JH; van Tellingen O
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():9-17. PubMed ID: 22727754
[TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatographic separation and extraction investigation for the simultaneous determination of mefloquine and its carboxylic acid metabolite.
Bergqvist Y; Eckerbom S; Larsson N; Churchill FC
J Chromatogr; 1988 Jun; 427(2):295-305. PubMed ID: 3261731
[TBL] [Abstract][Full Text] [Related]
12. An automated sample preparation and high performance liquid chromatographic method for the determination of MK-591, a novel leukotriene biosynthesis inhibitor, in human plasma.
Lin C; Hsieh JY; Matuszewski BK; Dobrinska MR
J Pharm Biomed Anal; 1996 Aug; 14(11):1601-8. PubMed ID: 8877868
[TBL] [Abstract][Full Text] [Related]
13. Determination of the newer quinolones levofloxacin and moxifloxacin in plasma by high-performance liquid chromatography with fluorescence detection.
Schulte S; Ackermann T; Bertram N; Sauerbruch T; Paar WD
J Chromatogr Sci; 2006 Apr; 44(4):205-8. PubMed ID: 16620519
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic method for the analysis of a candidate 8-aminoquinoline antileishmanial drug using oxidative electrochemical detection.
Anders JC; Theoharides AD; Thomas LM; Smyth MH; Chung H
J Chromatogr; 1984 Nov; 311(1):117-23. PubMed ID: 6520152
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of pyrimethamine and mefloquine in human plasma by high-performance liquid chromatography with ultraviolet detection.
Guenzi A; Cappelletti G; Scala A; Zanetti M
J Chromatogr; 1989 Sep; 494():219-30. PubMed ID: 2584319
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
Rivière JH; Back DJ; Breckenridge AM; Howells RE
Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
[TBL] [Abstract][Full Text] [Related]
17. Gas chromatographic determination of mefloquine in human and dog plasma using electron-capture detection.
Dadgar D; Climax J; Lambe R; Darragh A
J Chromatogr; 1985 Jan; 337(1):47-54. PubMed ID: 3872308
[TBL] [Abstract][Full Text] [Related]
18. Determination of pyrimethamine in human plasma after administration of fansidar of fansidar-mefloquine by means of high-performance liquid chromatography with fluorescence detection.
Timm U; Weidekamm E
J Chromatogr; 1982 Jun; 230(1):107-14. PubMed ID: 6980889
[TBL] [Abstract][Full Text] [Related]
19. Liquid-phase microextraction combined with high-performance liquid chromatography for the enantioselective analysis of mefloquine in plasma samples.
dos Santos Magalhães IR; Bonato PS
J Pharm Biomed Anal; 2008 Apr; 46(5):929-36. PubMed ID: 17367978
[TBL] [Abstract][Full Text] [Related]
20. Determination of mefloquine by electron-capture gas chromatography after phosgene derivatization in biological samples and in capillary blood collected on filter paper.
Bergqvist Y; Churchill FC; Mount DL
J Chromatogr; 1988 Jul; 428(2):281-90. PubMed ID: 3265137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
